sun pharma glp 1 Gains Approval for Generic Semaglutide in South Africa to Treat Type 2 Diabetes, ETPharma * Bariatric Fusion GLP Sun Pharma Hits 52-Week High
Description
Compounded GLP-1 medications are not FDA-approved as finished products and have not been reviewed by the FDA for safety, effectiveness, or quality as finished formulations
Lilly and Novo commended the FDA's confirmation that there is no clinical need to compound these drugs
What's even more impressive is that 57% of participants lost more than 20% of their body weight
Considerations for Oral Semaglutide Potential Side Effects: Like the injectable version, oral semaglutide can cause side effects like nausea, stomach discomfort and diarrhea
